Multiple in vitro investigations have demonstrated an upregulation of Beclin-1, ATG7, LC3-II, and p62 expression levels in malignancies associated with breast cancer (BC) and chronic myeloid leukemia (CML) [28,33,54]. The gene discussed is BECN1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.